(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid

peroxisome proliferator activated receptor alpha ; Mus musculus







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35397395 Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation. 2022 Jul 1
2 33775978 Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice. 2021 Dec 1 1
3 33821665 Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development. 2021 Jun 22 1
4 34502311 Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion. 2021 Aug 30 1
5 32584895 A novel selective PPARα modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms. 2020 2
6 32872333 Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy. 2020 Aug 28 1
7 33204884 Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet. 2020 Nov 1
8 31771164 Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model. 2019 Nov 23 1
9 30041488 The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice. 2018 Jul 23 4